In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • More than 250 female business and community leaders attended the fourth annual Susan F. Smith Center for Women's Cancers Executive Council, Beyond Boston Luncheon to benefit breast and ovarian cancer research. Speakers included Dr. Ann Partridge, Dr. Eric Winer, and WCVB reporter and cancer survivor, Kelley Tuthill.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • Extending tamoxifen treatment to 10 years significantly improved a women's chances of surviving breast cancer and reduced the risk of the cancer coming back, a new study shows. Dr. Eric Winer said while only about 10 percent of women in the study were premenopausal, the benefits were similar to those for women after menopause, indicating that a new long-term strategy is now an option for them. (Full article requires a subscription)

Tags: BreastCancer, Hormones, Prevention

  • Dr. Harold Burstein said the new data on the extended use of tamoxifen may push more patients to consider longer durations of anti-estrogen therapy, but they will need to be aware of the trade-offs, including mild side-effects and more serious, but rare cancer risks.

Tags: BreastCancer, Hormones, Prevention

  • A new study suggests that women should be taking the breast cancer drug tamoxifen for twice as long as is now customary. Dr. Eric P. Winer said that even women who completed their five years of tamoxifen months or years ago might consider starting on the drug again. Dr. Judy Garber added that while many women don't feel well while taking hormone therapies like tamoxifen, they consider it their safety net.

Tags: BreastCancer, Hormones, Prevention

  • Dr. Beth Overmoyer said women with Inflammatory Breast Cancer are often initially misdiagnosed because most doctors are not familiar with the disease.

Tags: BreastCancer

  • Dana-Farber has been given one of three, $100,000 research grants by The Terri Brodeur Breast Cancer Foundation's Scientific Advisory Committee.

Tags: BreastCancer, Grants, Honors

  • A new study shows the number of mastectomies is on the rise. Dr. Mehra Golshan explains one reason why is that women are worried about the cancer coming back in the breast or occurring in the opposite one.

Tags: BreastCancer

  • A study in the journal Cancer suggests that breast cancer patients who opt for lumpectomies with radiation might have a small survival advantage compared with those who have mastectomies. Dr. Mehra Golshan says it is hard to imagine that less surgery with radiation gives a better outcome.

Tags: BreastCancer, Radiation

  • Dana-Farber patient Peter Devereaux and his oncologist, Kathryn Ruddy, MD, MPH, were featured in a story on NBC.com about male breast cancer. Devereaux is one of several marines who developed breast cancer after serving in Camp Lejeune in North Carolina.

Tags: BreastCancer

  • Dr. Eric Winer comments on the FDA's recent approval of the breast cancer drug Kadcyla. He says clinical trials show that the drug is both highly effective and has few side effects.

Tags: BreastCancer

Showing 11-20 of 73 items